Vitamin D Metabolism in Chronic Kidney Disease Patients
Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
To determine whether or not chronic kidney disease (CKD), stages III-V and ESRD , is
associated with altered vitamin D metabolism related to fibroblast growth factor-23 (FGF-23)
stimulation of Cyp24 and whether they have resistance to elevations of 25 Hydroxyvitamin D
(25(OH)D3) after cholecalciferol supplementation.
To determine if such resistance is related to enhanced catabolism of (25(OH)related to
elevated levels of FGF-23.
Phase:
N/A
Details
Lead Sponsor:
Memphis VA Medical Center
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins